Hepatitis C Quick Start: A guide for the clinician by Kathleen M. Davis, NP
With the U.S. Preventative Services Task Force (USPSTF) recommendation that all people ages 18 and up be tested for HCV infection, it is anticipated that 800,000 new cases will be diagnosed. With a number that large, treatment accessibility needs expanding.
What is chronic hepatitis C? What are extra hepatic manifestations? What is the current treatment, and is it curative? Can any medical provider treat HCV?
Since 2011 I’ve been caring for individuals who have chronic HCV infection. In the fall of 2019 I began treating my patients with the direct-acting antivirals (DAAs).
From the days of non-specific, poorly tolerated, dismal results interferon, to the present day well-tolerated, over 95% effective pangenotypic DAAs, this journey has been a tremendously rewarding experience.
I have so much to tell you! I’ve put it all down in this accessible, comprehensive, evidence based book. Topics include:
- Hepatitis infection overview
- Unique properties of the virus
- Lab testing and interpretation
- Genotype and disease progression
- No more biopsies
- Special considerations in addiction medicine
- Treatment visit timeline and guidelines
- Telemedicine experience
- Long-term monitoring
- Patient testimonies
- Patient education tools
- Footnotes and Bibliography
After reading Quick Start, you won’t just know the guidelines for HCV treatment and prevention, you’ll understand why it is a serious worldwide epidemic worthy of our attention and action.